e-VITA: European-Japanese Virtual Coach for Smart Ageing (WAVE II)

Sponsor
Istituto Nazionale di Ricovero e Cura per Anziani (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05835856
Collaborator
European Union (Other)
240
4
5
7.3
60
8.2

Study Details

Study Description

Brief Summary

The study is a multicentre Proof-of-Concept. The general objective of the e-VITA project is to develop a personalized virtual coach capable of interacting with its elderly interlocutor. The experimentation will be carried out in 4 sites: Italy, France, Germany and Japan.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual coach with NAO robot
  • Device: Virtual coach with Google Nest Hub (2e generation) group
  • Device: Virtual coach with Gatebox device
  • Device: virtual coach with CelesTE robot
  • Other: booklet
N/A

Detailed Description

The general objective of the e-VITA project is to improve well-being for older adults and thereby promote active and healthy ageing, contribute to independent living, and reduce risks of social exclusion of older adults by making use a virtual coach by 240 healthy older adults recruited from Europe (France, Germany and Italy) and Japan. The study is a multicenter Proof-of-Concept study with a duration of the intervention of six months.

The multidisciplinary consortium collaborating in this project will develop an innovative ICT-based virtual coaching system to detect subtle changes in physical, cognitive, psychological and social domains of older adult's daily life. The e-VITA virtual coach will thus provide personalized recommendations and interventions, for sustainable wellbeing in a smart living environment at home.

The different components of the system are:
  • Coaches, consisting of social robots, that will interact with the users and are guided by apps;

  • Sensors (both wearable and domestic) to detect physiological parameters, physical activities, and behavior of the users; these sensors are: the Huawei smart band (wearable), the NeU device (wearable), and the DeltaDore system (domestic).

  • Smartphones (the chatbot to provide insights, suggestion, and stimulation about healthy nutrition and physical exercise; the social platform to encourage users to share their interests).

These components (coaches, sensors, chatbot and social platform) together with a main software named Use Cases Configurator (UCC) constitute the Virtual Coach.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
e-VITA: European-Japanese Virtual Coach for Smart Ageing (WAVE II)
Anticipated Study Start Date :
May 22, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: NAO robot group

Device: Virtual coach with NAO robot
The coaching device used is the softbank NAO 5 and NAO 6 humanoid interactive mobile robot. These robot platform allows multimodal natural language interaction and robot autonomous movement.

Experimental: Google Nest Hub (2e generation) group

Device: Virtual coach with Google Nest Hub (2e generation) group
The coaching device used is Google Nest Hub (2e generation). This is a connected speaker enriched with a 7-chip touch screen. It has a loudspeaker and 3 microphones, making interaction possible.

Experimental: Gatebox group

Device: Virtual coach with Gatebox device
The coaching device used is the Gatebox, a hologram like device which the user can interact. There are internal sensors such as a camera and a microphone allow the user to converse with the projected character. It connects to the Internet via a wireless LAN. With infrared rays and Bluetooth, it can also be connected to household appliances and other devices.

Experimental: CelesTE robot group

Device: virtual coach with CelesTE robot
The coaching device used is the CelesTE robot, a prayer companion designed for Christian Catholic users.The intended main function of CelesTE is to be a "guardian angel", especially thought for elderly people. It can be a prayer companion, and contains a vast number of teachings, including the whole Bible. Its AI is capable of keeping a short conversation, in which the user may ask and receive an answer about a sensitive topic (such as happiness, death, faith, etc.). It can also printout a selection of contents. The coaching device CelesTE will be substituted by DarumaTO for the Japanese centers.

Other: Control group

Other: booklet
Participant in the control group will receive a booklet containing information and activities on well-being

Outcome Measures

Primary Outcome Measures

  1. Change in the Quality of Life [baseline and 6 months later]

    The EQ-5D-5L scale consists of five dimensions: mobility, independence, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, mild problems, moderate problems, severe problems and extreme problems. The participant is asked to indicate his/her health status by ticking the box corresponding to the most appropriate statement in each of the five dimensions. The numbers from the five dimensions can be combined into a 5-digit number that describes the health status of the participant.

Secondary Outcome Measures

  1. Change in usability [At 3 and 6 months from baseline]

    The System Usability Scale (SUS) is a reliable tool for measuring usability. It consists of a10 item questionnaire with five response options for respondents from 'Strongly agree' to 'Strongly disagree'.

  2. Change in frailty status [baseline and 6 months later]

    The Clinical Frailty Scale (CFS) divides the older participants into 9 classes based on the information provided by them and their relatives: between 1 and 3 the patient is non-frail, pre-frail if 4, he is frail from 5 to 9.

  3. Change in nutritional capacity [baseline and 6 months later]

    The Short Food frequency questionnaires scale (FFQ) is used to estimate the frequency of daily food intake over a period of time. The FFQ asks for the frequency of certain food intake (once daily, once or twice a week, once or twice a month), and the approximate serving size. The questionnaire asks for information on the habitual intake of the food and is not to quantify the actual amount of nutrients ingested.

  4. Change in affinity with technology [baseline and 6 months later]

    The Affinity for Technology Interaction (ATI) measures a person's interaction-related affinity with technology. It consists of a total of nine items and uses a six-point Likert scale from 1 = completely disagree to 6 = completely agree.

  5. Change in cognitive status [baseline and 6 months later]

    Montreal Cognitive Assessment (MoCA) is a cognitive test validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI). Scores on the MoCA range from zero to 30. A score of 26 and higher is considered normal.

  6. Change in psychological mood [baseline and 6 months later]

    The Geriatric Depression scale 5-items version (GDS-5 items) questionnaire assesses the current condition of the patient's mood. Scores >1 are indicative for depression.

  7. Change in performance status [baseline and 6 months later]

    Short Physical Performance Battery (SPPB) is a short battery of tests designed to assess the function of the lower limbs. This scale consists of 3 different sections: balance assessment, evaluation of walking on 4 linear meters, evaluation of the ability to perform, for 5 consecutive times, the sit to stand from a chair, without using the upper limbs. The total scale score therefore has a range from 0 to 12. A total score below 10 indicates frailty and a high risk of disability and falls.

  8. Change in person's need for technology [baseline and 6 months later]

    The Assistive Technology Device Predisposition Assessment (ATDPA-5 - scales B and E) assesses the person's need for technology. It has two parts. A part on the individual with 9 items assessing functional capacities and 11 items on well-being. These first 20 items are to be filled in on a Likert scale of 5, ranging from 1: poor/not satisfied to 5: excellent/very satisfied. Finally, this last part also assesses personal and psychosocial characteristics. There is no threshold value for these last items. The second part deals with technological tools with 12 items highlighting their expectations in terms of benefits towards three technological tools. There is no threshold for this scale, but the scores range from 0 to 60 (sum of the statements).

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Able to stand and walk unaided;

  • No acute or untreated medical problems;

  • Montreal Cognitive Assessement test (MOCA) ≥ 22;

  • Geriatric Depression Scale (GDS) < 9;

  • Short performance physical battery (SPPB) ≥ 7

  • Clinical Frailty Scale score between 2 and 4.

Exclusion Criteria:
  • Use of active implant or not-implant medical devices;

  • Allergy to nichel;

  • A myocardial infarction or stroke within 6 months;

  • Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;

  • Uncontrolled hypertension;

  • Pacemaker or implantable cardioverter defibrillator;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Broca Hospital Paris France
2 Diocesan Caritas Association for the Archdiocese of Cologne Cologne Germany
3 IRCCS INRCA Hospital Ancona Italy 60127
4 Tohoku University -Smart Ageing Research Center Miyagi Japan

Sponsors and Collaborators

  • Istituto Nazionale di Ricovero e Cura per Anziani
  • European Union

Investigators

  • Study Director: Roberta Bevilacqua, IRCCS INRCA, Ancona, Italy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Istituto Nazionale di Ricovero e Cura per Anziani
ClinicalTrials.gov Identifier:
NCT05835856
Other Study ID Numbers:
  • INRCA_005_2023
First Posted:
Apr 28, 2023
Last Update Posted:
Apr 28, 2023
Last Verified:
Apr 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Istituto Nazionale di Ricovero e Cura per Anziani

Study Results

No Results Posted as of Apr 28, 2023